Commitments and Contingencies (Details Narrative) - USD ($)	May 31, 2022	Mar. 31, 2025	Jun. 21, 2023
Product Liability Contingency [Line Items]
Milestone payment, amount			$ 6,000,000
Kem Pharm [Member]
Product Liability Contingency [Line Items]
Cash consideration from sale of assets	$ 12,800,000
Liabilities assumed	$ 5,200,000
Aldoxorubicin [Member] | Maximum [Member]
Product Liability Contingency [Line Items]
Milestone payment, amount		$ 316,000
Arimoclomol [Member]
Product Liability Contingency [Line Items]
Milestone payment, amount		3,650,000
Arimoclomol [Member] | XOMA Agreement [Member]
Product Liability Contingency [Line Items]
Milestone payment, amount		3,250,000
Innovive [Member]
Product Liability Contingency [Line Items]
Future earnout merger consideration		$ 18,300,000